IN-B009
/ Korea Kolmar
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 09, 2021
Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)
(clinicaltrials.gov)
- P1; N=40; Recruiting; Sponsor: HK inno.N Corporation
Clinical • New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1